Inicio › Carcinoma de células escamosas de cabeza y cuello › Nueva York › Queens
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Queens, NY
20 estudios para Carcinoma de células escamosas de cabeza y cuello buscan participantes en centros de Queens y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
ReclutandoFase 3
- Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills · A 3 mi de distancia
- Queens Cancer Center, Rego Park · A 3 mi de distancia
- Northwell Health/Center for Advanced Medicine, Lake Success · A 9 mi de distancia
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
ReclutandoFase 3
- Memorial Sloan Kettering Nassau, Uniondale · A 13 mi de distancia
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ReclutandoFase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · A 11 mi de distancia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutandoFase 2
- NYU Langone Hospital - Long Island, Mineola · A 11 mi de distancia
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
ReclutandoFase 2
- Memorial Sloan Kettering Nassau, Uniondale · A 13 mi de distancia
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
ReclutandoFase 1/2
- START New York, Lake Success · A 9 mi de distancia
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
ReclutandoFase 2
- Perlmutter Cancer Center at NYU Langone Health, Mineola · A 11 mi de distancia
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ReclutandoFase 2
- Long Island Jewish Medical Center, New Hyde Park · A 9 mi de distancia
- Northwell Health/Center for Advanced Medicine, Lake Success · A 9 mi de distancia
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
ReclutandoFase 1
- Site 107 - START New York - Long Island, Lake Success · A 9 mi de distancia
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- START New York Long Island, Lake Success · A 9 mi de distancia
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
ReclutandoFase 2/3
- NYU Langone Hospital - Long Island, Mineola · A 11 mi de distancia
- Memorial Sloan Kettering Nassau, Uniondale · A 13 mi de distancia
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
ReclutandoFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- START-New York Long Island, Lake Success · A 9 mi de distancia
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- Clinical Research Alliance, Inc, Westbury · A 14 mi de distancia
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
ReclutandoFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · A 10 mi de distancia
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · A 9 mi de distancia
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · A 27 mi de distancia
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ReclutandoFase 1
- START New York Long Island, LLC, Lake Success · A 9 mi de distancia
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
ReclutandoFase 2
- Memorial Sloan Kettering Nassau, Uniondale · A 13 mi de distancia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
ReclutandoFase 3
- Northwell Health Cancer Institute, Lake Success · A 9 mi de distancia
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
Ensayos de Carcinoma de células escamosas de cabeza y cuello en otras ciudades
- Houston, TX47 estudios
- Los Angeles, CA42 estudios
- Boston, MA40 estudios
- Nashville, TN39 estudios
- New York City, NY39 estudios
- St. Louis, MO28 estudios
- Arlington, VA26 estudios
- Chicago, IL26 estudios
- Philadelphia, PA26 estudios
- Atlanta, GA24 estudios
- San Antonio, TX22 estudios
- Pittsburgh, PA22 estudios
Otros estudios en Queens
- Cáncer de seno64 estudios
- Cáncer de pulmón de células no pequeñas49 estudios
- Cáncer del colon y del recto31 estudios
- Cáncer metastásico28 estudios
- Cáncer de ovario28 estudios
- Cáncer de próstata27 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de endometrio25 estudios
- Cáncer de pulmón22 estudios
- Leucemia mielógena aguda21 estudios
- Mieloma múltiple20 estudios
- Cáncer de páncreas20 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.